We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

14 hedge funds and large institutions have $1.19M invested in NeuroMetrix, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

27% more funds holding

Funds holding: 1114 (+3)

23% more capital invested

Capital invested by funds: $967K → $1.19M (+$225K)

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$512K +$168K +6,542 +54%
Vanguard Group
2
Vanguard Group
Pennsylvania
$226K
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$156K +$5.21K +203 +4%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$103K +$19.7K +770 +26%
Citadel Advisors
5
Citadel Advisors
Florida
$98K +$49.1K +1,913 +114%
VF
6
Virtu Financial
New York
$43K +$40.1K +1,564 New
UBS Group
7
UBS Group
Switzerland
$27K +$23.1K +900 +957%
Morgan Stanley
8
Morgan Stanley
New York
$18K +$16.9K +659 New
BlackRock
9
BlackRock
New York
$4K -$872 -34 -18%
Osaic Holdings
10
Osaic Holdings
Arizona
$4K +$4.31K +168 New
TRCT
11
Tower Research Capital (TRC)
New York
$1K +$1.33K +52 New
Squarepoint
12
Squarepoint
New York
-$73K -2,692 Closed
TSS
13
Two Sigma Securities
New York
-$49K -1,802 Closed
Bank of America
14
Bank of America
North Carolina
+$51 +2 +100%
ASN
15
Advisory Services Network
Georgia
+$333 +13 New

NURO Hedge Fund Activity: Q2 2021 in Review

14 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2021, worth a combined $1.19M — up 23% from $967K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NURO positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $168K. The largest seller was Squarepoint, exiting entirely with an estimated $73K sold.

  • 14 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2021, up from 11 in Q1 2021.
  • Funds reported $1.19M of NeuroMetrix, Inc. Common Stock stock for Q2 2021, up 23% quarter-over-quarter.
  • 5 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2021 and 2 closed out, a net change of +3 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2021 was Renaissance Technologies, an estimated $168K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q2 2021 was Squarepoint, an estimated $73K sold.

Based on aggregated 13F filings for Q2 2021.